PRPO Precipio, Inc. Insider Trading

COO Sabet Ahmed Zaki buys 19 PRPO shares at $27.93; 4 of 4 prior buys at ticker well-timed at 90-day mark, 100% win rate cross-ticker.

Sabet Ahmed Zaki, Chief Operating Officer, purchased 19 shares of Precipio, Inc. at $27.93 on 2026-04-01, expanding his holdings to 1,034 shares. His track record at this specific ticker shows all four prior open-market buys generated positive 90-day returns (ranging from +8.6% to +82.1%), with each purchase well-timed relative to subsequent price movement. Cross-ticker, his open-market trading history spans 4 prior buys with a 100.00% 90-day win rate and average 90-day return of +33.7%. The current price of $27.25 sits 7.2% below the 52-week high of $29.35, and the company posted $6.8M quarterly revenue with negative earnings ($-79.0K) and 29.8% annual revenue growth, indicating operational scale-up despite current unprofitability. The consistency of his prior purchase timing relative to 90-day outcomes, combined with the current valuation proximity to the 52-week high and the company's revenue growth trajectory, provides a measurable historical context for evaluating this transaction's signal.

COO Sabet Ahmed Zaki buys 20 shares at $23.40; 3 of 3 prior PRPO purchases followed by 90d gains (+20%, +24%, +82.1%).

Sabet Ahmed Zaki, COO of Precipio Inc., purchased 20 shares at $23.40 on 2026-01-02, bringing his holdings to 735 shares (+2.8%). His timing track record at this ticker is notably strong: all 3 prior open-market buys at PRPO were well-timed at the 90-day mark, with subsequent returns of +20.0%, +24.0%, and +82.1%. The current price of $22.98 sits -12.5% from the 52-week high but +25.2% over 90 days, positioning this purchase within a stretch of recent gains. Notably, the company remains unprofitable (net income $-79.0K over the latest quarter) despite annual revenue growth of +22.0%, creating a backdrop where insider accumulation may signal either confidence in operational improvements or a contrarian entry point, but the consistent pattern of well-timed prior purchases at this ticker warrants attention from investors monitoring insider behavior relative to fundamental recovery prospects.

COO Sabet Ahmed Zaki buys 31 shares of PRPO at $16.30; stock now $25.62, up 18.2% in 30 days and 79.7% in 90 days.

Sabet Ahmed Zaki, Chief Operating Officer, purchased 31 shares at $16.30 on 2025-07-08, increasing his holdings to 690 shares (+4.7%). The stock has appreciated significantly since the transaction: $25.62 current price represents an approximate 57% gain from the purchase price, with 18.2% 30-day and 79.7% 90-day appreciation. His prior buy at the same ticker on 2025-04-02 delivered a 90-day return of +82.1%, indicating a pattern of purchases ahead of sustained rallies. However, the company remains unprofitable (net income $-79.0K in latest quarter, full-year net income was negative) despite revenue growth of +22.0% year-over-year, creating a disconnect between insider accumulation and fundamental profitability that investors should note.

COO Sabet Ahmed Zaki buys 25 PRPO shares at $19.50; 90-day history shows 2 of 2 prior buys well-timed, +24.0% and +82.1% returns

Sabet Ahmed Zaki, Chief Operating Officer of Precipio, purchased 25 shares at $19.50, bringing his holdings to 715 shares (+3.6% increase). This marks his third open-market buy of PRPO stock. His prior two purchases at this ticker, made on 2025-07-08 and 2025-04-02, both demonstrated favorable 90-day outcomes: +24.0% and +82.1% respectively, with a 90-day win rate of 100% across the two trades. The current price of $25.62 sits 30-day change +18.2% and 90-day change +79.7% — indicating sustained upward momentum that aligns with the pattern of his previous two purchases at this ticker. However, the company remains unprofitable (net income $-79.0K in the latest quarter) despite 22% annual revenue growth, which introduces fundamental risk and suggests the recent price appreciation may not yet reflect sustainable earnings power.

Director Sandberg bought 1,399 shares in 2 transactions at blended avg $10.00 on 2025-05-30, now holding 40,175 shares (up 3.6%)

Richard A. Sandberg, Director, purchased 1,399 shares across 2 separate transactions on 2025-05-30 at a blended average price of $10.00, spending $13,985.52 total. This purchase follows rapid accumulation: prior trades at PRPO on 2025-05-20, 2025-05-21 (×2), 2025-05-22, and 2025-05-27 all remain within the outcome-measurement window (outcomes not yet determinable). The stock has advanced 55.2% over 30 days and trades 6.9% below its 52-week high of $10.14. However, context is critical: Precipio is unprofitable (full-year net income was negative) with quarterly net income of -$884,000.00 against revenue of $4,929,000.00, despite 22.0% annual revenue growth. The recent cluster of five buys within ten days, combined with an unprofitable balance sheet, warrants monitoring to determine whether this accumulation reflects evolving business conditions or represents a pattern driven by other factors.

Director Richard Sandberg bought 101 PRPO shares at $9.80 on 2025-05-27, fifth consecutive buy in 7 days.

Sandberg purchased 101 shares at $9.80, bringing his holdings to 38,776 shares post-transaction. This buy is noteworthy in context: it is the fifth consecutive open-market buy at PRPO within a 7-day window (2025-05-19 through 2025-05-27), signaling repeated accumulation activity at the same ticker. His cross-ticker track record shows 6 prior buys with an average 90-day return of +19.7% and a 100.00% win rate, suggesting a pattern of favorable entry timing elsewhere. However, the five prior PRPO buys are too recent (all within the last week) to have measurable 30-day or 90-day outcomes; timing efficacy at this ticker remains unproven. Precipio is a small-cap company ($15.1M market cap) with negative net income ($-884,000.00 last quarter) and no current profitability, though revenue grew 22.0% year-over-year. The stock has risen 64.8% in the last 30 days and 31.5% in the last 90 days, currently trading at $9.96, 1.8% below its 52-week high of $10.14. The repeated buying pattern over a compressed timeframe warrants attention to whether this reflects conviction in a turnaround or response to specific corporate developments.

Director Sandberg buys 500 PRPO shares at $9.33; 5 consecutive buys in 8 days amid +66.5% 30-day rally; company unprofitable

Richard A Sandberg, a Director, purchased 500 shares at $9.33 on 2025-05-22, bringing his holdings to 38,675 shares. This transaction is the sixth purchase within an 8-day window (2025-05-19 through 2025-05-27), occurring as PRPO stock surged +66.5% over 30 days and +44.2% over 90 days, now trading at $10.04 near the $10.14 52-week high. The concentrated buying pattern during a strong rally, combined with the company's unprofitable status (latest quarterly net income of $-884,000 despite +22.0% annual revenue growth and a $15.2M market cap), raises questions about whether these purchases reflect conviction or opportunistic accumulation at accelerating valuations. Investors should note that prior PRPO trade outcomes remain unmeasurable (all occurred within the last 8 days), limiting ability to assess whether Sandberg's timing decisions at this specific ticker have historically validated future price action.

Director SANDBERG purchases 8,035 shares at $9.27 avg, expanding holdings 26.7% to 38,175 shares in unprofitable PRPO

Director Richard A Sandberg executed 2 separate purchases totaling 8,035 shares for $74,473.75 on 2025-05-21, increasing his stake by 26.7% relative to pre-transaction holdings of 30,140 shares. The blended average price of $9.27 sits near the current price of $9.75 and within the 52-week range ($4.44–$10.14), though the stock has gained +78.9% over the past 30 days following a -3.8% decline over 90 days. The company remains unprofitable (net income $-884,000.00 for the latest quarter; full-year net income was negative), though revenue grew +22.0% year-over-year and the market cap stands at $14,742,107.25. His cross-ticker track record shows 4 prior buys averaging +5.8% 30-day return and +19.7% 90-day return with a 100.00% win rate, though at PRPO specifically he has executed 5 prior trades in rapid succession (three within the past 3 days), making the timing and motivation for this concentrated purchasing activity worth examining in context of company fundamentals and recent price momentum.

Director SANDBERG bought 4,965 shares at blended avg $8.43 on 2025-05-19 to 2025-05-20, raising holdings 19.7% to 30,140 shares.

Director Richard A. Sandberg purchased 4,965 shares across 2 separate transactions totaling $41,867.91 at an average price of $8.43, a 17.5% discount to the current price of $9.90. This represents a substantial 19.7% increase in his holdings over 2 days. His cross-ticker track record shows 3 prior buys with an average 90-day return of +19.7% and a 100% win rate, suggesting consistent acumen in timing open-market purchases. However, Precipio remains unprofitable with negative annual net income of $884,000.00 despite 22% annual revenue growth, and the company trades at a market cap of $15.0M with recent quarterly revenue of only $4.9M, indicating an early-stage biotech or specialized firm where director-level participation carries both conviction signal and heightened execution risk.

COO Sabet Ahmed Zaki purchased 79 shares of PRPO at $6.00 (Apr 2), boosting stake to 939 shares; stock down 48.0% from 52-week high.

Sabet Ahmed Zaki, serving as Chief Operating Officer, purchased 79 shares at $6.00 on April 2, 2025, increasing his holdings by 9.2%. The transaction occurred when the stock was trading near the bottom of its 52-week range, down 48.0% from its high of $10.14, and has declined a further 27.4% in the 30 days since the purchase. Precipio is a micro-cap company ($7.9M market cap) that reported net losses of $626,000 in its most recent quarter despite showing 22.0% annual revenue growth, signaling operational challenges beneath growth metrics. The absolute dollar value of this purchase ($473.75) is modest relative to both the company's scale and typical executive compensation levels, making it difficult to interpret the transaction as a meaningful confidence signal about near-term prospects.